The Gabelli Healthcare & Wellness Trust

The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

The Gabelli Healthcare & Wellness Trust trades as GRX on NYSE. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $15.28M of revenue and $2.29M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

The Gabelli Healthcare & Wellness Trust can be compared against peers such as Bancroft Fund Ltd., Baron Health Care Fund Retail Shares, Western Asset Mortgage Opportunity Fund Inc., The Gabelli Multimedia Trust Inc., Integrity Mid-North American Resources Fund Class A, MainStay Epoch Capital Growth Fund - Class A.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $136.21M, beta of 0.83, and return on equity of +1.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

GRX currently shows total debt of $70.72M and beta of 0.83. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: NPORT-P (2026-06-01 00:00:00), 8-K (2026-05-07 00:00:00), DEFA14A (2026-03-19 00:00:00), DEF 14A (2026-03-19 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.gabelli.com/Template/fundinfo.cfm?tid=MTNlMzU=&bid=ZDg2&mid=NWRiNDg=&num=MzM0MGQ=&kid=NTA4NzQ=&pid=obj&rid=811-=edoc_dnuf

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.